003000 — Bukwang Pharm Co Income Statement
0.000.00%
Last trade - 00:00
- KR₩405bn
- KR₩341bn
- KR₩126bn
- 27
- 16
- 33
- 10
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 168,194 | 169,660 | 182,491 | 190,909 | 125,928 |
Cost of Revenue | |||||
Gross Profit | 84,249 | 71,641 | 75,758 | 79,429 | 47,074 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 158,656 | 169,170 | 176,869 | 191,140 | 164,151 |
Operating Profit | 9,537 | 490 | 5,622 | -231 | -38,223 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1,362 | -8,300 | 3,787 | -1,033 | -39,569 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7,435 | -10,105 | -2,797 | -4,249 | -34,407 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -7,412 | -7,203 | -917 | -2,475 | -31,330 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -7,412 | -7,203 | -917 | -2,475 | -31,330 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -103 | -72 | -15.5 | -36.6 | -451 |
Dividends per Share |